Literature DB >> 16002043

Poly(ADP-ribose)polymerase-1 is required for integration of the human immunodeficiency virus type 1 genome near centromeric alphoid DNA in human and murine cells.

Masanori Kameoka1, Souichi Nukuzuma, Asako Itaya, Yasuharu Tanaka, Katsuya Ota, Yoshiaki Inada, Kazuyoshi Ikuta, Koichiro Yoshihara.   

Abstract

This study examined the efficiency of human immunodeficiency virus type 1 (HIV-1) integration in poly(ADP-ribose)polymerase-1 (PARP-1)-deficient murine cells and in human cell lines transfected with small interfering RNA against PARP-1 (PARP-1 siRNA). To semi-quantify the amount of integrated HIV-1 genome, real-time nested PCR was carried out using primers specific for Alu and alphoid DNA combined with primers for the HIV-1 genome. The results showed that the integration efficiency of the HIV-1 genome near Alu DNA, which is randomly distributed in the chromosome, is reduced in PARP-1-deficient murine cells, but not in PARP-1 siRNA-transfected human cells. By contrast, the integration efficiency of the HIV-1 genome near alphoid DNA, which is localized in the centromere region, is significantly reduced in PARP-1-deficient murine cells and in PARP-1 siRNA-transfected human cells. These results suggest that PARP-1 is required for HIV-1 integration near the centromere region both in human and murine cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002043     DOI: 10.1016/j.bbrc.2005.06.104

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Ku80 participates in the targeting of retroviral transgenes to the chromatin of CHO cells.

Authors:  Christel Masson; Stéphanie Bury-Moné; Elvire Guiot; Asier Saez-Cirion; Damien Schoëvaërt-Brossault; Corinne Brachet-Ducos; Olivier Delelis; Frédéric Subra; Laurence Jeanson-Leh; Jean-François Mouscadet
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

Review 2.  HIV integrase inhibitors: 20-year landmark and challenges.

Authors:  Mathieu Métifiot; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2013

3.  Poly(ADP-ribose) polymerase 1 promotes transcriptional repression of integrated retroviruses.

Authors:  Murilo T D Bueno; Daniel Reyes; Luis Valdes; Adarsh Saheba; Eduardo Urias; Crystal Mendoza; Oliver I Fregoso; Manuel Llano
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

4.  Poly(ADP-ribose) polymerase-1 silences retroviruses independently of viral DNA integration or heterochromatin formation.

Authors:  Denisse A Gutierrez; Luis Valdes; Che Serguera; Manuel Llano
Journal:  J Gen Virol       Date:  2016-03-30       Impact factor: 3.891

5.  The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity.

Authors:  Slava Rom; Nancy L Reichenbach; Holly Dykstra; Yuri Persidsky
Journal:  Front Microbiol       Date:  2015-08-25       Impact factor: 5.640

Review 6.  Activation of the DNA Damage Response by RNA Viruses.

Authors:  Ellis L Ryan; Robert Hollingworth; Roger J Grand
Journal:  Biomolecules       Date:  2016-01-06

7.  Structure-based mechanism of action of a viral poly(ADP-ribose) polymerase 1-interacting protein facilitating virus replication.

Authors:  Woo-Chang Chung; Junsoo Kim; Byung Chul Kim; Hye-Ri Kang; JongHyeon Son; Hosam Ki; Kwang Yeon Hwang; Moon Jung Song
Journal:  IUCrJ       Date:  2018-10-31       Impact factor: 4.769

Review 8.  The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.

Authors:  Anthony R Fehr; Sasha A Singh; Catherine M Kerr; Shin Mukai; Hideyuki Higashi; Masanori Aikawa
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 9.  Phosphorylation Targets of DNA-PK and Their Role in HIV-1 Replication.

Authors:  Andrey Anisenko; Marina Kan; Olga Shadrina; Anna Brattseva; Marina Gottikh
Journal:  Cells       Date:  2020-08-16       Impact factor: 6.600

Review 10.  Therapeutic potential of RNA interference against cellular targets of HIV infection.

Authors:  Jia Zhang; Y O Wu; Li Xiao; Kai Li; L L Chen; P Sirois
Journal:  Mol Biotechnol       Date:  2007-09-15       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.